Search Results for 'prostate psa'
prostate psa published presentations and documents on DocSlides.
Prostate Cancer Screening and Early Prostate Cancer Management
by hadly
Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Onco...
PROSTATE CANCER AND BPH Prostate cancer
by josephine
The second most common cancer diagnosed in men. Th...
Prostate Cancer Screening in 2013: Reports of its Death Are
by min-jolicoeur
Norm D. Smith, M.D.. Associate Professor. Co-Dire...
New Ways of Managing Prostate Cancer
by olivia-moreira
Jahangeer . M.Malik. Consultant Clinical Oncology...
Prostate Cancer Screening in Canada
by donetrand
Environmental Scan. April 2017. Background. The Ca...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
Prostate cancer: To screen or not to screen
by evans
–. To treat . or not to treat. Dr Oliver Klein �...
Effect of a lower-intensity PSA-based screening intervention on prostate cancer mortality: the CAP
by sophia2
SWAG Urology SSG. 11. th . October 2018 . Context ...
Some prostatic diseases Ali Al Khader, M.D.
by hadly
Faculty of Medicine. Al-Balqa’ Applied Universit...
mCSPC Patient detailing ADT: androgen deprivation therapy; BPH: benign prostatic hyperplasia; DRE:
by olivia
Extraprostatic. . Exteneion. ; MRI: magnetic reso...
6th Annual Interdisciplinary
by giovanna-bartolotta
Prostate Cancer . Congress. Meeting in . a. Box....
A Prostate Cancer Update: Screening, Over Diagnosis, and Tr
by faustina-dinatale
Matthew D. Katz, M.D.. Assistant Professor. Urolo...
Biochemically Recurrent Prostate Cancer: Optimizing Detecti
by alexa-scheidler
This program will include a discussion of investi...
Prostate cancer isn’t colorblind
by stefany-barnette
Ruth Etzioni. Roman Gulati . Lurdes . inouE. Dham...
Prostate Cancer Screening in the Post-USPSTF Era
by lindy-dunigan
Alon Z. Weizer, MD, MS. Associate Professor of Ur...
Therapies for Clinically Localized Prostate Cancer
by fauna
Background A National Institutes of Health NIH pan...
Optimizing Sleep, Exercise and Nutrition in Prostate Cancer
by topslugger
Stacy Loeb, MD MSc PhD (Hon). @LoebStacy. Professo...
MicroRNA—a small non-coding RNA: An efficient biomarker for prostate
by LetsGetDrunk
cancer. Khanmi. . Kasomva. ,. Ph.D. . Research . ...
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Pathology of the male genitourinary tract
by wilson
Pathology of Prostate
1.Distinguish acute and chr...
In biochemical recurrence after curative treatment of prost
by lindy-dunigan
1- has a detection rate of 10-20% when PSA: 1-2 n...
Matthew D. Galsky, MD Director, GU Medical Oncology
by luanne-stotts
Tisch. Cancer Institute. Icahn School of Medicin...
rostate cancer PC is the most common cancer and the leading cause of
by callie
279
in Mexico, PC prevalence and the consequent im...
Learning from webinar On Friday 4 February, an online event took place to mark World Cancer Day.
by jade
The event was . organised. by Wessex Voices, Wess...
Target trial emulation Causal inference from observational data
by cappi
Joy Shi, PhD. Instructor of Epidemiology. CAUSAL a...
Correlation of Digital Rectal Examination Findings with Findings on
by eleanor
G12
Histopathology of the Prostate in Patients wit...
Effect of 18 F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results
by unita
Metser. U et al. Published Online: . January 25,...